Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914590 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Caroline Molinaro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France. Hauptthemen laut MEDLINE: Topoisomerase I Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, Comités Pas de Calais, Ligue Contre le Cancer, Comités Nord et Aisne, CNRS, the University of Lille, Chevreul Institute (FR 2638), Ministère de l’Enseignement Supérieur et de la Recherche, Région Hauts de France.
Abstract (Originalsprache)
Topoisomerases are interesting targets in cancer chemotherapy. Here, we describe the design and synthesis of a novel copper(II) indenoisoquinoline complex, WN198. The new organometallic compound exhibits a cytotoxic effect on five adenocarcinoma cell lines (MCF-7, MDA-MB-231, HeLa, HT-29, and DU-145) with the lowest IC50 (0.37 ± 0.04 μM) for the triple-negative MDA-MB-231 breast cancer cell line. Below 5 µM, WN198 was ineffective on non-tumorigenic epithelial breast MCF-10A cells and Xenopus oocyte G2/M transition or embryonic development. Moreover, cancer cell lines showed autophagy markers including Beclin-1 accumulation and LC3-II formation. The DNA interaction of this new compound was evaluated and the dose-dependent topoisomerase I activity starting at 1 μM was confirmed using in vitro tests and has intercalation properties into DNA shown by melting curves and fluorescence measurements. Molecular modeling showed that the main interaction occurs with the aromatic ring but copper stabilizes the molecule before binding and so can putatively increase the potency as well. In this way, copper-derived indenoisoquinoline topoisomerase I inhibitor WN198 is a promising antitumorigenic agent for the development of future DNA-damaging treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
- Univ. Lille, CNRS, Centrale Lille, Univ. Artois, UMR 8181-UCCS-Unité de Catalyse et Chimie du Solide, F-59000 Lille, France.
- Univ. Lille, Inserm U1003-PHYCEL-Physiologie Cellulaire, F-59000 Lille, France.
ORCID-Profile: Caroline Molinaro, Marc F Lensink, Jérôme de Ruyck, Lydie Pélinski, Alain Martoriati
Förderung
- Ligue Contre le Cancer, Comités Pas de Calais
- Ligue Contre le Cancer, Comités Nord et Aisne
- CNRS, the University of Lille, Chevreul Institute (FR 2638), Ministère de l’Enseignement Supérieur et de la Recherche, Région Hauts de France
- Ligue Contre le Cancer, Comités Nord Pas de Calais, Nord et Aisne
Zitieren
APA
Molinaro, C., Wambang, N., Pellegrini, S., Henry, N., Lensink, M. F., Germain, E., Bousquet, T., de Ruyck, J., Cailliau, K., Pélinski, L., & Martoriati, A. (2023). Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914590
Vancouver
Molinaro C, Wambang N, Pellegrini S, Henry N, Lensink MF, Germain E, et al. Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914590
BibTeX
@article{Molinaro2023,
author = {Molinaro, Caroline and Wambang, Nathalie and Pellegrini, Sylvain and Henry, Natacha and Lensink, Marc F and Germain, Emmanuelle and Bousquet, Till and de Ruyck, Jérôme and Cailliau, Katia and Pélinski, Lydie and Martoriati, Alain},
title = {Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914590}
}
EUVIMED